Trump administration will allow pharmacies to make popular peptides
The Department of Health and Human Services released a policy allowing small compounding pharmacies to make six popular peptides without Food and Drug Administration approval. Health and Human Services Secretary Robert F. Kennedy Jr. championed the move to expand access to the unapproved peptide injections, overriding agency scientists who opposed the policy. The Department of Health and Human Services stated that the policy does not establish clinical safety and effectiveness. The decision represents a major win for peptide proponents and health freedom advocates seeking wider availability of wellness peptides.
Listen to Live Briefing
Real-time synthesized voice briefing · Live Feeds Desk
- ✓ The Department of Health and Human Services released a policy that would allow compounding pharmacies to make six peptides that have not been approved by the Food and Drug Administration.
- ✓ Health and Human Services Secretary Robert F. Kennedy Jr. supported broader access to peptides and granted access, overruling the Food and Drug Administration.
- ✓ Food and Drug Administration scientific staffers opposed the Trump administration's move to ease access to the unproven peptide drugs.
- ✓ The Department of Health and Human Services stated that the policy does not establish clinical safety and effectiveness.
What changed
The Department of Health and Human Services issued a new policy allowing compounding pharmacies to manufacture six unapproved peptides.
Live updates
-
HHS Allows Pharmacies to Make Popular Unapproved Peptides
The Department of Health and Human Services released a policy allowing small compounding pharmacies to make six popular peptides without Food and Drug Administration approval. Health and Human Services Secretary Robert F. Kennedy Jr. championed the move to expand access to the unapproved peptide injections, overriding agency scientists who opposed the policy. The Department of Health and Human Services stated that the policy does not establish clinical safety and effectiveness. The decision represents a major win for peptide proponents and health freedom advocates seeking wider availability of wellness peptides.
Why it matters
The action bypasses traditional regulatory channels at the Food and Drug Administration, prompting pushback from agency scientific staff who had little input on the decision. Proponents of the alternative treatments cheered the directive as a shortcut to make popular wellness peptides more widely available in the United States. Critics and agency advisors have raised warnings regarding the safety of widespread unapproved peptide injections.
What is confirmed
- The Department of Health and Human Services released a policy that would allow compounding pharmacies to make six peptides that have not been approved by the Food and Drug Administration.
- Health and Human Services Secretary Robert F. Kennedy Jr. supported broader access to peptides and granted access, overruling the Food and Drug Administration.
- Food and Drug Administration scientific staffers opposed the Trump administration's move to ease access to the unproven peptide drugs.
- The Department of Health and Human Services stated that the policy does not establish clinical safety and effectiveness.
What to watch next
- Monitor whether small compounding pharmacies can meet the consumer demand for the six newly authorized peptides.
- Watch for any formal legal challenges or safety advisories issued by the Food and Drug Administration regarding the unapproved peptide injections.
confidence 100%Sources used for this update (25)
- www.newsday.com — Newsday | Long Island's & NYC's News Source - Newsday
- flipboard.com — Beloved singer’s wife killed after welcoming robbery suspects with lemonade
- NBC News — RFK Jr. takes shortcut to make some peptides more widely available
- The New York Times — RFK Jr. to Allow Broad Use of Unapproved Peptide Injections
- Reuters — US health department to allow temporary sale of some unapproved peptides
- CNN — FDA scientists opposed the Trump administration’s move to ease peptides access
- NPR — Trump administration will allow pharmacies to make popular peptides
- Ars Technica — Peptide peddlers cheer as RFK Jr. unilaterally grants access, overruling FDA
- Yahoo — RFK Jr says he will allow widespread unapproved injections despite his FDA advising people not to use them
- CBS News — RFK Jr. to ease access to unapproved peptides, draft policy states
- BBC — US Health Secretary RFK Jr to expand access to unapproved peptides
- www.clickondetroit.com — US bans imports from 3 Chinese biotech companies over forced labor allegations
Community Sentiment: How do you assess this situation?
Voice your perspective · Real-time aggregated sentiment from the Live Feeds community